Bristol/Sanofi Plan sNDA For Plavix Acute MI Subset Indication By Year-End
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Bristol-Myers Squibb and Sanofi-Aventis will file a Plavix supplemental NDA by the end of 2005 for the prevention of clinical events in patients with a history of acute ST-segment elevation myocardial infarction